Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Obesity

Novo Nordisk pursues preliminary injunction to block Eli Lilly weight-loss drug ads

Novo Nordisk is seeking a court injunction to stop Eli Lilly's drug advertisements. The Danish company claims Lilly's ads mislead consumers about treatment comparisons. Lilly denies wrongdoing and stands by its advertising claims. Both companies compete in the growing obesity and diabetes drug market. Novo Nordisk argues Lilly uses outdated…

The Economic Times

Make junk food costlier, tighten school canteen rules: Five steps ICMR suggests to curb childhood obesity

India faces a significant childhood obesity crisis with 41 million affected children. New government policies aim to curb unhealthy food marketing and improve school food options. Easy-to-understand food labels will help parents make informed choices for their families. Dedicated health taxes on unhealthy foods and beverages are also proposed. These…

The Economic Times

Eli Lilly Cleared Two More Trials For Its Next-Generation Obesity Drug. It Will Seek FDA Approval Next Year

After 80 weeks of treatment, obese, non-diabetic participants receiving retatrutide lost an average of 22.6% of their body weight while also showing improvements in several cardiometabolic risk factors.

International Business Times

From analysis to the latest developments in health,
read the most diverse news in one place.

Heart Attack Deaths Have Fallen Dramatically Over 33 Years: A New Study Pinpoints Exactly What Worked

A JAMA Cardiology 33-year analysis found modifiable risk factors drove a dramatic decline in U.S. heart attack deaths. But BMI and blood sugar-related deaths are increasing.

Medical Daily

Medicare's New GLP-1 Weight Loss Drug Program Launched July 1, but It Expires in 2027 with No Successor in Place

The Medicare GLP-1 Bridge launched July 1, 2026 at $50/month for eligible beneficiaries. It expires December 31, 2027, with the permanent BALANCE replacement indefinitely delayed.

Medical Daily

The First Oral GLP-1 Weight Loss Pill With No Food or Injection Requirements Is Now Available

Eli Lilly's Foundayo (orforglipron) is the first oral GLP-1 obesity pill with no food or water restrictions. FDA approved it April 1, 2026. Here is what patients should know.

Medical Daily

The GLP-1 paradox: too expensive to cover, too effective to cut

A founder and a former HHS CTO agree: GLPs are breaking the healthcare system. We need to move away from drug-first or diet-first obesity care.

Fortune

Read news from The Economist, FT, and more,
with one subscription

Gold card health scheme to cover obesity surgery

The National Health Security Office (NHSO) has expanded benefits under the Universal Coverage Scheme, commonly known as the 30-baht gold card scheme, to include surgery for patients with severe obesity who meet strict medical criteria.

Bangkok Post

Type 2 Diabetes Jumped 69% in Young Women, Nearly 60% Higher Than in Men, as Obesity Starts Earlier

A study reveals a 69% rise in type 2 diabetes among young women in England since 2011, highlighting early obesity as a key factor. The NHS is responding with targeted initiatives.

International Business Times UK

Target ultra-processed food to reduce obesity in Britain

Letter: James Capon responds to an editorial on the health select committee’s call for radical action to regulate food markets

The Guardian - UK

GLP-1 Drugs Like Ozempic Carry Elevated Risks of Muscle Loss and Malnutrition in Adults Over 65

GLP-1 drugs carry higher muscle loss, malnutrition, and bone density risks in adults over 65 that younger users don't face. Here's what older patients and prescribers need to know.

Medical Daily

Loneliness Is a Bigger Health Risk Than Obesity, Here Is What the Research Shows on Social Isolation

The study that changed how doctors think about lonelinessIn 2015, psychologist Julianne Holt-Lunstad at Brigham Young University published a meta-analysis in Perspectives on Psychological Science covering 148 studies and roughly 308,000 participants. The finding: people with strong social connections had a 50% greater likelihood of survival over a given period…

Times Life

A tax on sugary drinks in Egypt could reduce disease and save US$1.8 billion in healthcare costs: modelling study

Non-communicable diseases – heart disease, stroke, diabetes, cancer – are no longer just a rich-country problem. Across Africa, they are becoming the leading cause of death, driven in part by a simple and overlooked culprit: what people drink.

The Conversation

Why the same foods you eat during the day can lead to belly fat, higher blood sugar & poorer cholesterol levels at night; study has the answer

Night owls consuming high-energy foods late at night show greater body fat. Evening-types eat less in the morning and more after 8 pm. This eating pattern is associated with higher body fat percentage and obesity risk. Women preferring later bedtimes had poorer lipid profiles and glucose regulation. Meal timing, especially…

The Economic Times

Get all your
news in one place.

100's of premium titles.
One news app.

The Economic Times

US obesity crisis: Not losing weight despite exercising? American Heart Association study reveals the surprising truth about your health beyond the scale, blood pressure and cholesterol

Weight loss tips: Regular exercise offers significant health benefits, even without substantial weight loss. Increasing physical activity alone may not lead to major weight reduction. Strength training is crucial for preserving muscle mass during weight loss efforts. Maintaining weight loss often requires more extensive physical activity weekly. Successful weight management…

Medical Daily

Stopping Ozempic or Wegovy Leads to Nearly 2 Pounds of Weight Regain Per Month, Largest Review Finds

Oxford study of 9,341 adults finds stopping Ozempic or Wegovy causes ~1.8 lbs of weight regain per month. What patients need to know about GLP-1 discontinuation.

The Economic Times

Novo Nordisk's obesity drug Wegovy wins India approval to fight silent fatty liver killer

India's drug regulator approved Novo Nordisk's Wegovy for MASH treatment. This drug targets a serious progressive form of fatty liver disease. The approval follows a committee recommendation for adults with moderate to advanced liver fibrosis. Wegovy, containing semaglutide, was previously approved for chronic weight management. This marks a significant expansion…

The Guardian - UK

How can we better support families to make healthier food choices?

The food industry, government and wider society can build a healthier future for children and their families – but the issues are complex, as a recent panel of experts found

Get all your
news in one place.

100's of premium titles.
One news app.

MyLifeXP

Fatty Liver? These 3 Science-Backed Drinks May Help

Fatty liver disease often develops silently, showing few or no symptoms until the condition becomes more serious. Modern lifestyles, processed foods, lack of exercise, and excess alcohol have made it increasingly common worldwide. While there is no magic drink that can cure fatty liver, experts say that combining a healthy…

International Business Times UK

Energy Drinks Ban Sees England Block High-Caffeine Drinks for Under-16s From 2027

From April 2027, England will ban sales of high-caffeine energy drinks to under-16s, aiming to protect children's health amid concerns over caffeine's impact on sleep, concentration, and obesity.

Medical Daily

A Record 40 Million Americans Are Now Taking GLP-1 Weight-Loss Drugs as Medicare Coverage Begins

A Gallup survey shows 11% of Americans now take GLP-1 drugs for weight loss as Medicare begins covering them for $50 monthly. Here's what it means for you.

MyLifeXP

The Health Tests You Should Get In Your 20s Even If You Feel Perfectly Healthy

Feeling healthy does not always mean everything is perfect inside your body. High cholesterol, vitamin deficiencies, diabetes, high blood pressure, and even certain infections can go unnoticed for years without causing obvious symptoms. Your 20s are the ideal time to create a baseline for your health. Regular screenings are not…

The Guardian - UK

The Guardian view on obesity: put public health before food industry pressure

Editorial: Obesity reflects prices, advertising and access, not simply weak willpower. Ministers must now act

MyLifeXP

The Most Misunderstood Indian Foods And The Myths Around Them

Indian cuisine is one of the world's most diverse and nutritious food traditions. Built around grains, pulses, spices, dairy, and seasonal vegetables, it has evolved over centuries through local wisdom and regional practices. Yet many traditional foods have become victims of misinformation. Social media trends, fad diets, and half understood…

Medical Daily

Ozempic's Active Ingredient May Slow Biological Aging, First Human Clinical Trial Finds

A clinical trial published in Nature Communications found semaglutide slowed biological aging markers in adults with HIV. Here's what the research actually shows.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Imperial College London

The National Institutes of Health

163 stories

ICMR

110 stories

Nature Communications

92 stories

86 stories

the American Heart Association

86 stories

Bridge

77 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.